WIRB-Copernicus Group snaps up Velos eResearch for undisclosed price

Close-up of handshake between person in suit and person in business shirt.
Clinical research helper WIRB-Copernicus Group acquired Velos eResearch, a clinical trial management solutions provider, for an undisclosed price. (Getty Images)

WIRB-Copernicus Group has boosted its clinical trial management solutions business as it adds CTMS specialist Velos eResearch to its growing family.

The company will tap into Velos' internet platform solution, where it is able to streamline the management of institutional research by linking study status, patient enrollment, calendars, budgets, billing and electronic data capture by centralizing the management of research activities, the company said.

Under terms of the deal, Velos will continue to operate independently and will remain headquartered in Fremont, California.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

WCG partners with 93% of the institutions—and 90% of the academic medical centers—that conduct research in the U.S., the company said.

“WCG is privileged to serve more than 2,800 institutions, and we are thrilled to empower them with technology solutions that will increase the efficiency of their research programs,” Donald A Deieso, WCG’s chair and CEO, said in a statement.

Last summer, WCG acquired KMR Group and Metrics Consortium in a deal that strengthened the company’s market insights and intelligence division.

Suggested Articles

Qiagen is collaborating with Ares Genetics to develop new bioinformatics and assay solutions for research targeting antibiotic-resistant bacteria.

STA Pharmaceutical has signed an exclusive technology and marketing deal with Swiss biotech BioLingus.

Clinerion is partnering with Citeline to give clinical researchers a more comprehensive approach to making evidence-based decisions.